Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rapydan Topical Anaesthesia for Arterial Cannulation

This study has been completed.
The Cleveland Clinic
Population Health Research Institute
Information provided by (Responsible Party):
Kurt Rutzler, Medical University of Vienna Identifier:
First received: December 15, 2011
Last updated: March 15, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)